NEW YORK (TheStreet) -- TheStreet's Jim Cramer answers Twitter
(TWTR) questions from the floor of the New York Stock Exchange on Monday, and this week's first question deals with Walmart
Cramer says the stock could bounce on a technical basis, but he points to Dollar Tree
(DLTR) and Dollar General
(DG) , the latter of which was upgraded twice on Monday because of its bid to merge with Family Dollar
(FDO) . Cramer says Walmart is left out of the bottom and the top, so he does not want to own the stock until he sees some strategy that indicates the company has figured out how to operate dollar stores and high-end stores. He needs momentum in order to own a retailer, and Walmart does not have it in his opinion.
The next question asks about Yelp
(YELP) . The stock was at $60 and went to $70. The company reported a very good quarter and rose to $75, but then dropped into the $60 range again and some investors felt the company was not expanding its local listings quickly enough. Cramer disagreed with this and thinks Yelp has gone for gross margins. The company made money, and Cramer believes in CEO Jeremy Stoppelman. Cramer suggests investors buy the volatile stock when it drops $2 or $3.
Must Watch: Cramer Answers Twitter Questions on Walmart, Yelp, Kinder Morgan
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
The next user owns Kinder Morgan Energy Partners
and plans to go into Kinder Morgan
at some point. This person wants to know if he should wait for the deal to go through or sell KMP and buy KMI now. Cramer suggests he wait because he's going to get KMI anyway, so he should not sell KMP. Cramer says this is not a complicated transaction and if investors own El Paso Pipeline Partners
or KMP, then they will get KMI and should just happily take it.
Next, Cramer says WhiteWave
has more momentum than Hain Celestial
because plant-based foods are so strong and it has the Horizon brand. Cramer says Hain, which is in the $80 range, has stalled with a lot of bears around the stock, but betting against CEO Irwin Simon
has been a mistake and Cramer thinks the stock is just resting.
The next question asks if there is more risk in chasing Gilead Sciences
or continuing to hold Celgene
. Cramer says they are both terrific and undervalued in 2016 numbers compared to other big pharmaceutical companies. Cramer was surprised Gilead did not surge when it reported an amazing quarter thanks to its hepatitis C drug, Sovaldi. He thinks Celgene has a lot of irons in the fire and he wants to own both stocks.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he and Stephanie Link think could be potentially HUGE winners. Click here to see the holdings for FREE.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts